IGEA is a company that studies the clinical application of physical stimuli to biological systems. It focuses two main areas, such as orthopedics and oncology. The company develops electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes.